What podcasts say about Kit Rees

Every statement, with the speaker, the exact quote and the moment it was said.

What Kit Rees has said on podcasts

30 statements · 18 positive · 6 negative · 4 mixed · 2 neutral

on European energy stocksPositiveSep 1, 2026· Stock Movers
Higher oil prices are boosting energy stocks
“they're really boosting these stocks”
Listen at 0:48
Open the episode · Shell Gains, Gamma Rises, CVC Advisers Dips
on Brent crude oilPositiveSep 1, 2026· Stock Movers
Brent crude is heading toward $92 per barrel
“Brent heading towards $92 a barrel”
Listen at 0:51
Open the episode · Shell Gains, Gamma Rises, CVC Advisers Dips
on Energy companiesPositiveSep 1, 2026· Stock Movers
Concerns about tightening oil supply help energy companies
“these worries over tightening supply They really help these companies”
Listen at 1:16
Open the episode · Shell Gains, Gamma Rises, CVC Advisers Dips
on Stocks Energy IndexPositiveSep 1, 2026· Stock Movers
The European Stocks Energy Index is up 44% year to date
“it's up 44% year to date”
Listen at 1:32
Open the episode · Shell Gains, Gamma Rises, CVC Advisers Dips
on Gamma CommunicationsNegativeSep 1, 2026· Stock Movers
Gamma Communications shares plunged 40% in 2025
“in 2025, it saw the shares plunge by 40%”
Listen at 2:25
Open the episode · Shell Gains, Gamma Rises, CVC Advisers Dips
on UK company valuationsNegativeSep 1, 2026· Stock Movers
UK companies are trading at significant valuation discounts
“UK Inc on sale, given the big discounts we've seen in UK valuations”
Listen at 2:37
Open the episode · Shell Gains, Gamma Rises, CVC Advisers Dips
on CVC Advisors sharesNegativeSep 1, 2026· Stock Movers
CVC Advisors shares are down 3.3%
“it shares are down 3.3%”
Listen at 2:50
Open the episode · Shell Gains, Gamma Rises, CVC Advisers Dips
on CVC Advisors acquisition of Body CoatNegativeSep 1, 2026· Stock Movers
CVC Advisors may miss out on acquiring Bodycote
“it looks like it might be missing out on a deal for a UK firm called Body Coat”
Listen at 2:53
Open the episode · Shell Gains, Gamma Rises, CVC Advisers Dips
on CVC Advisors acquisition of Body CoatPositiveSep 1, 2026· Stock Movers
CVC could still submit a higher offer for Bodycote
“CVC could still put in a higher offer”
Listen at 3:07
Open the episode · Shell Gains, Gamma Rises, CVC Advisers Dips
on BodycoatPositiveSep 1, 2026· Stock Movers
Bodycote's North American exposure makes it attractive
“Bodycoat has exposure to, you know, a big global exposure, especially to North America, which makes it quite an attractive company”
Listen at 3:25
Open the episode · Shell Gains, Gamma Rises, CVC Advisers Dips
on AstraZenecaNegativeAug 17, 2026· Stock Movers
AstraZeneca shares remain depressed since July
“AstraZeneca shares are pretty depressed since July”
Listen at 1:26
Open the episode · AstraZeneca Climbs, Glencore Rises, Argenx Surges
on AstraZenecaPositiveAug 17, 2026· Stock Movers
AstraZeneca shares may be experiencing a modest rebound
“it could just be rebounding a little bit”
Listen at 1:35
Open the episode · AstraZeneca Climbs, Glencore Rises, Argenx Surges
on AstraZenecaNegativeAug 17, 2026· Stock Movers
AstraZeneca shares are currently depressed relative to their level since July.
“AstraZeneca shares are pretty depressed since July really”
Listen at 1:41
Open the episode · AstraZeneca Climbs, Glencore Rises, Argenx Surges
on Copper pricePositiveAug 17, 2026· Stock Movers
London copper prices are approaching a record high
“copper prices in London coming close to a record high”
Listen at 1:53
Open the episode · AstraZeneca Climbs, Glencore Rises, Argenx Surges
on Mining stocksNeutralAug 17, 2026· Stock Movers
Mining stocks closely track metals prices
“They really track metals prices really closely.”
Listen at 1:59
Open the episode · AstraZeneca Climbs, Glencore Rises, Argenx Surges
on Artificial IntelligencePositiveAug 17, 2026· Stock Movers
AI has been the major driver of copper demand this year
“AI has been the big demand driver this year.”
Listen at 2:05
Open the episode · AstraZeneca Climbs, Glencore Rises, Argenx Surges
on CopperPositiveAug 17, 2026· Stock Movers
Copper demand is currently very high
“there's just a huge demand for copper right now”
Listen at 2:17
Open the episode · AstraZeneca Climbs, Glencore Rises, Argenx Surges
on AI-driven copper demandPositiveAug 17, 2026· Stock Movers
AI has been a major driver of copper demand this year.
“AI has been the big demand driver this year”
Listen at 2:20
Open the episode · AstraZeneca Climbs, Glencore Rises, Argenx Surges
on CopperPositiveAug 17, 2026· Stock Movers
Copper is a key component used in data centers.
“It's used in data centers. So it's a really, really key component.”
Listen at 2:24
Open the episode · AstraZeneca Climbs, Glencore Rises, Argenx Surges
on Copper demandPositiveAug 17, 2026· Stock Movers
Demand for copper is currently very high.
“there's just a huge demand for copper”
Listen at 2:32
Open the episode · AstraZeneca Climbs, Glencore Rises, Argenx Surges
on GlencorePositiveAug 17, 2026· Stock Movers
Recent positive developments are pushing Glencore shares higher
“all this good news is just pushing the shares higher today”
Listen at 2:33
Open the episode · AstraZeneca Climbs, Glencore Rises, Argenx Surges
on US-bound copper shipmentsPositiveAug 17, 2026· Stock Movers
US-bound copper shipments are supporting mining companies’ share prices.
“this is just really buoying these mining companies”
Listen at 2:42
Open the episode · AstraZeneca Climbs, Glencore Rises, Argenx Surges
on Biotech stocksMixedAug 17, 2026· Stock Movers
Biotech stocks depend heavily on individual drug-development success
“biotech stocks, they can be a little bit binary because their fortunes really depend on whether a particular drug is successful in its development”
Listen at 2:59
Open the episode · AstraZeneca Climbs, Glencore Rises, Argenx Surges
on argenx experimental myositis treatmentPositiveAug 17, 2026· Stock Movers
argenx reported positive trial results for an experimental myositis treatment.
“it had a slatestail trial results for experimental treatment for myositis”
Listen at 3:06
Open the episode · AstraZeneca Climbs, Glencore Rises, Argenx Surges
on Biotech sharesNeutralAug 17, 2026· Stock Movers
Biotech shares can experience very large price swings
“you can see some really, really big swings in the shares there”
Listen at 3:09
Open the episode · AstraZeneca Climbs, Glencore Rises, Argenx Surges
on ArgenxPositiveAug 17, 2026· Stock Movers
Argenx shares are up about 10%
“its shares are now positive on the air that up about 10%”
Listen at 3:13
Open the episode · AstraZeneca Climbs, Glencore Rises, Argenx Surges
on Biotech stocksMixedAug 17, 2026· Stock Movers
Biotech stocks can experience highly binary outcomes.
“biotech stocks, they can be a little bit binary”
Listen at 3:14
Open the episode · AstraZeneca Climbs, Glencore Rises, Argenx Surges
on Biotech stocksMixedAug 17, 2026· Stock Movers
Biotech stocks’ fortunes depend on whether particular drugs succeed in development.
“their fortunes really depend on whether a particular drug is successful in its development”
Listen at 3:17
Open the episode · AstraZeneca Climbs, Glencore Rises, Argenx Surges
on Biotech drug developmentMixedAug 17, 2026· Stock Movers
Biotech drug-development outcomes are roughly evenly balanced
“it's a sort of 50-50 chance of things working out, really”
Listen at 3:18
Open the episode · AstraZeneca Climbs, Glencore Rises, Argenx Surges
on ArgenxPositiveAug 17, 2026· Stock Movers
argenx shares are up approximately 10% year-to-date.
“the shares are now positive on the year. They're up about 10%”
Listen at 3:28
Open the episode · AstraZeneca Climbs, Glencore Rises, Argenx Surges

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.